DW
David Weill

David Weill insider trades: TransMedics Group (TMDX) stock buys and sales

TransMedics Group Last trade Sep 11, 2026 16 Form 4 filings
$1.2M
Sold, last 12 months
2 sales
$109K
Bought, last 12 months
1 buy
10
Open-market trades
since 2019
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 11, 2026TMDX↑ Buy$109K
Mar 4, 2026TMDX↓ Sell$524K
Dec 3, 2025TMDX↓ Sell$693K
May 23, 2025TMDX↓ Sell$91K
May 29, 2024TMDX↓ Sell$169K
May 10, 2024TMDX↓ Sell$325K
Aug 29, 2023TMDX↑ Buy$155K
Feb 27, 2023TMDX↓ Sell$455K
Nov 10, 2022TMDX↓ Sell$1.2M
Nov 11, 2019TMDX↑ Buy$170K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TMDX insiders

Open-market trades in the last 12 months

About David Weill's insider trades

David Weill is an insider at TransMedics Group (TMDX). Since Nov 11, 2019, David has reported 3 open-market purchases worth $434K and 7 sales worth $3.5M on SEC Form 4. In the last 12 months: 1 buy ($109K) and 2 sales ($1.2M).

Their filings also include grants and awards (7 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.